SENSEX 81373.75 (-0.09)
Nifty 50 24716.6 (-0.14)
Nifty Bank 55903.4 (0.28)
Nifty IT 37061.85 (-0.70)
Nifty Midcap 100 57775.55 (0.62)
Nifty Next 50 67039.8 (0.42)
Nifty Pharma 21394.1 (-0.22)
Nifty Smallcap 100 18095.55 (1.19)
NIKKEI 225 37470.67 (-1.30)
HANG SENG 23157.97 (-0.57)
S&P 5931.77 (-0.02)
BSE Code : 524404 | NSE Symbol : MARKSANS | ISIN : INE750C01026 | Industry : Pharmaceuticals |
Hot Pursuit 30-May-2025 (09:33) Marksans Pharma gets regulatory nod for marketing type-2 diabetes medication in UK
Corporate News 30-May-2025 (09:13) Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK
Corporate News 20-May-2025 (12:49) Board of Marksans Pharma recommends final dividend
Results 20-May-2025 (07:46) Marksans Pharma consolidated net profit rises 15.66% in the March 2025 quarter
Corporate News 19-May-2025 (13:29) Relonchem receives marketing authorization for Sennosides 7.5 mg tablets
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others